FDA to expedite clearance for Pear ' s digital therapeutic for opioid addiction

Pear Therapeutics announced today that reSET-O, a digital therapeutic for opioid use disorder, has received an Expedited Access Pathway (EAP) designation from the FDA. The EAP designation doesn ' t mean that the FDA has cleared the product, only that it has committed to fast-tracking it through the clearance process because of its timely public health value.  
Source: mobihealthnews - Category: Information Technology Source Type: news